Medizinische Universität Graz - Research portal
Dey Saptaswa |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Lackner, A; Burner, T; Brandner, M; Dey, S; Aigner, S; Buxhofer-Ausch, V; Geroldinger-Simic, M; Iselin, C; Chang, YT; Tsai, YC; Altrichter, S; Wolf, P; Kimeswenger, S; Guenova, E; Hoetzenecker, W
Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
Br J Dermatol. 2025;
Doi: 10.1093/bjd/ljaf102
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Lackner, A; Burner, T; Brandner, M; Aigner, S; Buxhofer-Ausch, V; Geroldinger-Simic, M; Dey, S; Iselin, C; Chang, Y; Tsai, Y; Wolf, P; Kimeswenger, S; Guenova, E; Hötzenecker, W
Immunogenic cell death (ICD) and ICDdependent dendritic cell activation triggered by extracorporeal photopheresis in CTCL
EXP DERMATOL. 2025; 34(3):
Web of Science
2024
Full paper/article (Journal)
** Dey, S; Vieyra-Garcia, PA; Joshi, AA; Trajanoski, S; Wolf, P
Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model
FRONT IMMUNOL. 2024; 15: 1255859
Doi: 10.3389/fimmu.2024.1255859
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sternberg, C; Raigel, M; Limberger, T; Trachtová, K; Schlederer, M; Lindner, D; Kodajova, P; Yang, J; Ziegler, R; Kalla, J; Stoiber, S; Dey, S; Zwolanek, D; Neubauer, HA; Oberhuber, M; Redmer, T; Hejret, V; Tichy, B; Tomberger, M; Harbusch, NS; Pencik, J; Tangermann, S; Bystry, V; Persson, JL; Egger, G; Pospisilova, S; Eferl, R; Wolf, P; Sternberg, F; Högler, S; Lagger, S; Rose-John, S; Kenner, L
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.
Mol Cancer. 2024; 23(1):245
Doi: 10.1186/s12943-024-02114-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Dey, S; Sorger, H; Schlederer, M; Perchthaler, I; Kenner, L; Moriggl, R; Wolf, P
Targeting the hyperactive STAT3/5 Pathway in Cutaneous T-Cell Lymphoma: superior efficacy of multi-kinase inhibitor IQDMA over conventional PUVA therapy
EUR J CANCER. 2024; 211: S14-S15.
Doi: 10.1016/j.ejca.2024.114371
[Poster]
Web of Science
FullText
FullText_MUG
** Dey, S; Vieyra-Garcia, PA; Joshi, AA; Trajanoski, S; Wolf, P
Enhanced Phototherapeutic Efficacy Through Microbial Modulation in Cutaneous T-Cell Lymphoma delays tumour growth and increases survival in the murine EL4 model
EUR J CANCER. 2024; 211: S5-S6.
Doi: 10.1016/j.ejca.2024.114349
[Poster]
Web of Science
FullText
FullText_MUG
** Lackner, A; Kimeswenger, S; Brandner, M; Aigner, S; Buxhofer-Ausch, V; Geroldinger-Simic, M; Dey, S; Wolf, P; Chang, YT; Tsai, YC; Guenova, E; Hötzenecker, W
Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation triggered by Extracorporeal Photopheresis in CTCL
EUR J CANCER. 2024; 211: S6-S7.
Doi: 10.1016/j.ejca.2024.114351
[Poster]
Web of Science
FullText
FullText_MUG
2023
Abstract (Journal)
** Dey, S; Vieyra-Garcia, P; Joshi, A; Wolf, P
Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumor growth and increases survival in a murine model
J INVEST DERMATOL. 2023; 143(5):S178-S178.-1st International Societies for Investigative Dermatology Meeting; MAY 12-13, 2023; Tokyo, JAPAN.
[Poster]
Web of Science
** Dey, S; Wolf, P
Inhibition of STAT3/5 pathway by multi-kinase inhibitor IQDMA reduces tumor growth and outperforms conventional phototherapeutic treatment regime in cutaneous T cell lymphoma murine model
J INVEST DERMATOL. 2023; 143(11):S373-S373.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
2022
Full paper/article (Journal)
** Alonso, IGD; Zujo, L; Wiest, I; Kodajova, P; Timelthaler, G; Edtmayer, S; Zrimsek, M; Kollmann, S; Giordano, C; Kothmayer, M; Neubauer, HA; Dey, S; Schlederer, M; Schmalzbauer, BS; Limberger, T; Probst, C; Pusch, O; Hogler, S; Tangermann, S; Merkel, O; Schiefer, AI; Kornauth, C; Prutsch, N; Zimmerman, M; Abraham, B; Anagnostopoulos, J; Quintanilla-Martinez, L; Mathas, S; Wolf, P; Stoiber, D; Staber, PB; Egger, G; Klapper, W; Woessmann, W; Look, TA; Gunning, P; Turner, SD; Moriggl, R; Lagger, S; Kenner, L
PDGFR beta promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
MOL CANCER. 2022; 21(1): 172
Doi: 10.1186/s12943-022-01640-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sorger, H; Dey, S; Vieyra-Garcia, PA; Pölöske, D; Teufelberger, AR; de, Araujo, ED; Sedighi, A; Graf, R; Spiegl, B; Lazzeri, I; Braun, T; Garces, de, Los, Fayos, Alonso, I; Schlederer, M; Timelthaler, G; Kodajova, P; Pirker, C; Surbek, M; Machtinger, M; Graier, T; Perchthaler, I; Pan, Y; Fink-Puches, R; Cerroni, L; Ober, J; Otte, M; Albrecht, JD; Tin, G; Abdeldayem, A; Manaswiyoungkul, P; Olaoye, OO; Metzelder, ML; Orlova, A; Berger, W; Wobser, M; Nicolay, JP; André, F; Nguyen, VA; Neubauer, HA; Fleck, R; Merkel, O; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
EMBO Mol Med. 2022; 14(12):e15200
Doi: 10.15252/emmm.202115200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Alonso, IGD; Zujo, L; Krsmanovic, I; Kodojova, P; Schlederer, M; Timelthaler, G; Edtmayer, S; Giordano, C; Kothmayer, M; Neubauer, HA; Dey, S; Pusch, O; Hogler, S; Tangermann, S; Schiefer, A; Kornauth, C; Stoiber, PWD; Staber, P; Klapper, W; Woessmann, W; Gunning, P; Turner, S; Moriggl, R; Lagger, S; Kenner, L
PDGFR beta DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
LEUKEMIA RES. 2022; 121: S69-S69.
Web of Science
** Dey, S; Sorger, H; Vieyra-Garcia, P; Teufelberger, A; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
STAT3/5 locus gain is a disease marker and therapeutic target in leukemic/ cutaneous T cell lymphoma
J INVEST DERMATOL. 2022; 142(12): S254-S254.
Web of Science
2021
Abstract (Journal)
** Dey, S; Sorger, H; Vieyra-Garcia, P; Araujo, ED; Graf, R; Spiegl, B; Schlederer, M; Graier, T; Perchthaler, I; Fink-Puches, R; Cerroni, L; Surbek, M; Pirker, C; Berger, W; Orlova, A; Herling, M; Merkel, O; Neubauer, HA; Gunning, PT; Heitzer, E; Kenner, L; Moriggl, R; Wolf, P
STAT5 is a therapeutically targetable vulnerability in leukemic cutaneous T-cell lymphoma
EXP DERMATOL. 2021; 30(3):E100-E101.
[Poster]
Web of Science
** Dey, S; Sorger, H; Vieyra-Garcia, PA; de Araujo, ED; Graf, R; Spiegl, B; Lazzeri, I; Herling, M; Neubauer, HA; Merkel, O; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
Chromosome # 17q (17q11.2-17q21.31) gain is a disease marker and therapeutic vulnerability in Sezary Syndrome
EXP DERMATOL. 2021; 30: 14-14.-4th Inflammatory Skin Disease Summit; NOV 03-06, 2021; New York, NY.
[Poster]
Web of Science
2020
Full paper/article (Journal)
** Benezeder, T; Painsi, C; Patra, V; Dey, S; Holcmann, M; Lange-Asschenfeldt, B; Sibilia, M; Wolf, P
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.
Elife. 2020; 9:
Doi: 10.7554/eLife.56991
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Abstract (Journal)
** Vieyra-Garcia, PA; Jakic, M; Dey, S; Perchtaler, I; Wolf, P
Cutaneous T cell lymphoma mouse model used to study the therapeutic mechanisms of phototherapy
EUR J CANCER. 2019; 119: S14-S14.-EORTC-CLTF Meeting on Cutaneous Lymphoma - Insights in Research and Catient Care; SEP 26-28, 2019; Athens, GREECE.
[Poster]
Web of Science
2018
Abstract (Journal)
** Dey, S; Vieyra-Garcia, PA; Kenner, L; Merkel, O; Wolf, P
Inhibition of STAT5 with IQDMA reduces cell viability in cutaneous T cell lymphoma cells in-vitro and decreases tumor growth in a lymphoma animal model
EXP DERMATOL. 2018; 27: 28-29.-3rd Inflammatory Skin Disease Summit; DEC 12-15, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science